Back
CNX Resources Vs. Kymera Therapeutics Industry Stock Comparison
Sell
49
CNX
CNX Resources
Last Price:
27.02
Seasonality Move:
1.14%
Buy
62
KYMR
Kymera Therapeutics
Last Price:
44.79
Seasonality Move:
25.63%
Sell
49
CNX Resources (CNX)
is a Sell
Is CNX Resources a Buy, Sell or Hold?
- The current CNX Resources [CNX] share price is $26.77. The Score for CNX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- CNX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $46.88. The Score for KYMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CNX Stock Price Chart
What is CNX Resources's stock price today?
-
The CNX Resources share price today is $26.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNX is experiencing slight buying pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $46.88
The current trend is moderately bearish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
CNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.29 | Buy |
| Relative Strength Index (14 RSI): | 50.15 | Buy |
| Chaikin Money Flow: | 967589 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.94 - 27.62) | Sell |
| Bollinger Bands (100): | (24.06 - 26.56) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.1 | Buy |
| Relative Strength Index (14 RSI): | 55.23 | Buy |
| Chaikin Money Flow: | 209294 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.77 - 48.09) | Buy |
| Bollinger Bands (100): | (32.74 - 44.46) | Buy |
CNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.22 | Sell |
| 20-day SMA: | 27.1 | Sell |
| 50-day SMA: | 26.13 | Buy |
| 200-day SMA: | 23.2 | Buy |
| 8-day EMA: | 27.06 | Sell |
| 20-day EMA: | 26.93 | Sell |
| 50-day EMA: | 26.25 | Buy |
| 200-day EMA: | 23.81 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.77 | Buy |
| 20-day SMA: | 46.4 | Buy |
| 50-day SMA: | 42.99 | Buy |
| 200-day SMA: | 35.58 | Buy |
| 8-day EMA: | 46.64 | Buy |
| 20-day EMA: | 46.04 | Buy |
| 50-day EMA: | 43.26 | Buy |
| 200-day EMA: | 36.12 | Buy |
CNX Resources Earnings Growth & CNX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.09 per share, an increase this year of $0.02 per share, and an increase next year of $0.35 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.51 per share.
CNX Resources Technical Analysis
| Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||